CIK: 1366074 - Address: C/O Inhibrx Biosciences, Inc., 11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/16/24 17:12
9/12/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOP.m62915.730405925I
9/10/24 17:00
9/6/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOP.m67115.250445885I
9/3/24 17:31
8/29/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOP.m59714.920405841I
8/22/24 16:29
8/20/24
INBXInhibrx Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOP.m51812.960405801I
3/1/23 16:41
2/28/23
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOS-225.020003,046I
1/24/23 18:46
1/23/23
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOS.m-66125.420-26-13,046I
12/20/22 16:59
12/19/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOS-66425.560-26-13,072I
11/18/22 17:06
11/17/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOS-72527.880-26-13,098I
10/18/22 16:37
10/17/22
INBXInhibrx, Inc.CAHealthBioPrdBiological Products, (No DiagLappe MarkCADOCEOS-76929.590-26-13,124I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact